NO991519D0 - Administrasjon av svakt sure medikamenter til kolon - Google Patents

Administrasjon av svakt sure medikamenter til kolon

Info

Publication number
NO991519D0
NO991519D0 NO991519A NO991519A NO991519D0 NO 991519 D0 NO991519 D0 NO 991519D0 NO 991519 A NO991519 A NO 991519A NO 991519 A NO991519 A NO 991519A NO 991519 D0 NO991519 D0 NO 991519D0
Authority
NO
Norway
Prior art keywords
colon
administration
mildly acidic
acidic drugs
drugs
Prior art date
Application number
NO991519A
Other languages
English (en)
Norwegian (no)
Other versions
NO991519L (no
Inventor
Peter James Watts
Original Assignee
Danbiosyst Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk Ltd filed Critical Danbiosyst Uk Ltd
Publication of NO991519D0 publication Critical patent/NO991519D0/no
Publication of NO991519L publication Critical patent/NO991519L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991519A 1996-10-04 1999-03-29 Administrasjon av svakt sure medikamenter til kolon NO991519L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9620709.7A GB9620709D0 (en) 1996-10-04 1996-10-04 Colonic delivery of weak acid drugs
PCT/GB1997/002726 WO1998015265A1 (fr) 1996-10-04 1997-10-06 Apport dans le colon de medicaments contenant des acides faibles

Publications (2)

Publication Number Publication Date
NO991519D0 true NO991519D0 (no) 1999-03-29
NO991519L NO991519L (no) 1999-03-29

Family

ID=10800944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991519A NO991519L (no) 1996-10-04 1999-03-29 Administrasjon av svakt sure medikamenter til kolon

Country Status (17)

Country Link
US (1) US20020015729A1 (fr)
EP (1) EP0956006A1 (fr)
JP (1) JP2001501642A (fr)
KR (1) KR20000048939A (fr)
CN (1) CN1232386A (fr)
AU (1) AU732210B2 (fr)
BR (1) BR9712163A (fr)
CA (1) CA2264637A1 (fr)
CZ (1) CZ118899A3 (fr)
GB (2) GB9620709D0 (fr)
HU (1) HUP9904320A3 (fr)
IL (1) IL129185A0 (fr)
NO (1) NO991519L (fr)
NZ (1) NZ334313A (fr)
PL (1) PL332555A1 (fr)
SK (1) SK44299A3 (fr)
WO (1) WO1998015265A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1323418B1 (fr) * 2000-09-06 2010-08-11 Mitsubishi Tanabe Pharma Corporation Preparations de granules pour administration orale
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
CA2520321A1 (fr) * 2003-04-04 2004-10-14 Pharmacia Corporation Tablettes comprimees orales de formulations multiparticulaires a liberation prolongee
FR3008281B1 (fr) * 2013-07-15 2015-07-31 Chantelle Coque de soutien-gorge et son procede de fabrication
CA3098604A1 (fr) * 2018-05-03 2019-11-07 M.W. Encap Limited Formes posologiques pour l'administration de medicaments au tractus gastro-intestinal inferieur

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211777A (en) * 1977-11-25 1980-07-08 Fisons Limited Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
GB2253346A (en) * 1991-02-22 1992-09-09 John Rhodes Delayed release oral dosage forms for treatment of intestinal disorders
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
EP0520119A1 (fr) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Composition à base de diclofenac pour l'administration orale
HU227530B1 (en) * 1991-11-22 2011-07-28 Warner Chilcott Company Delayed-release compositions containing risedronate and process for their production
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
JP2916978B2 (ja) * 1993-08-25 1999-07-05 エスエス製薬株式会社 放出開始制御型製剤
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
AU5397496A (en) * 1995-03-28 1996-10-16 Janssen Pharmaceutica N.V. Low dose ridogrel formulations and their use for the treatme nt of inflammatory bowel diseases

Also Published As

Publication number Publication date
WO1998015265A1 (fr) 1998-04-16
CA2264637A1 (fr) 1998-04-16
AU732210B2 (en) 2001-04-12
NZ334313A (en) 2000-09-29
BR9712163A (pt) 2000-01-18
IL129185A0 (en) 2000-02-17
SK44299A3 (en) 2000-05-16
GB2333042B (en) 2000-10-18
CZ118899A3 (cs) 1999-07-14
NO991519L (no) 1999-03-29
JP2001501642A (ja) 2001-02-06
GB2333042A (en) 1999-07-14
AU4565597A (en) 1998-05-05
GB9620709D0 (en) 1996-11-20
US20020015729A1 (en) 2002-02-07
KR20000048939A (ko) 2000-07-25
CN1232386A (zh) 1999-10-20
GB9907298D0 (en) 1999-05-26
HUP9904320A3 (en) 2000-08-28
PL332555A1 (en) 1999-09-13
HUP9904320A2 (hu) 2000-06-28
EP0956006A1 (fr) 1999-11-17

Similar Documents

Publication Publication Date Title
FI972292A0 (fi) Administrering av diabetes
FI932655A (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
BR9706897B1 (pt) forma de dosagem farmacêutica.
BR9611367A (pt) Formulação farmacêutic liofilizada estável
PT1221918E (pt) Administracao de drogas sub-tenon
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
ATE187063T1 (de) Arzneimittel
BR9611626A (pt) Formulações farmacéuticas
NO962606L (no) Farmasöytisk sammensetning
ATE367150T1 (de) Arzneimittel
ATE264677T1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
PT907364E (pt) Composicao farmaceutica de libertacao sustida
NO981008D0 (no) Farmasöytisk formulering
NO985936L (no) Nasal administrasjon av desmopressin
NO981166L (no) Fremstilling av askorbylmonofosfater
ID25535A (id) Komposisi batangan yang terdiri dari tetesan-tetesan pelunak yang terperangkap terdispersi padanya
IS1985B (is) Lyfjafræðilegar örkúlur með valprósýru til inngjafar um munn
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
NO991519L (no) Administrasjon av svakt sure medikamenter til kolon
NO994619D0 (no) Farmasöytiske blandinger
LV11727A (lv) Farmaceitiska kompozicija
NO20003141D0 (no) Farmasøytiske blandinger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application